欢迎来到 phaRNA中国区代理商/公司/官网
全国咨询热线: 18771997407
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18771997407

传真:15172469628

邮箱:sales@amyjet.com

新闻中心
Toronto Research Chemicals.jpg

Toronto Research Chemical建立于1982年,致力于为生物医药研发人员提供小分子有机物,库存超过57000种,并通过一系列方法保证标准物质的纯度。

 

Toronto Research Chemicals, TRC, was founded in 1982 by Dr. David Dime to manufacture and supply researchers in the biomedical fields with specialized complex organic small molecules that were not commercially available. In 1983, the company was incorporated in Ontario as Toronto Research Chemicals Inc. It was initially located at the University of Toronto. As the business expanded, larger facilities were required to accommodate the growth.

 

Today, Toronto Research Chemicals Inc. employs about 150 full time staff, of which approximately 80 are PHD's, operating in a 65,000 square foot facility. TRC, currently manufactures and distributes in excess of 33,000 products to more than 65 countries.

 

Toronto Research Chemical的产品涵盖:

Activators; Affinity Chromatography; Agonists; Agro-Products; Aldehyde Labeling Reagents; Aldehydes; Amines; Amino Acids & Derivatives; Anti-virals; Antibiotics; Apoptosis; Benzodiazepines; Biotin Derivatives; Boron Derivatives; Carbohydrates; Catalysts; Charged Bifunctional Reagents; Charged Monofunctional Reagents; Chelating Agents & Ligands; Chiral Reagents; Chromatography Media; Cross Linking Reagents; Crosslinker; CyanineDyes; Detergents; Diagnostics; Dihydropyridine; Dopamines; DrugAnalogues; ElectrophoresisMaterials; Environmental; Enzyme Substrates; Ephedrines; Fatty Acids & Derivatives; Fentanyls; Fluorescent Labels &Indicators; Glucuronides; Glutathione S-Transferase Agents; Glycerols; Glycosidase Inhibitors; Heterocycles; Hydantoins; Impurities; Indole Derivatives; Inhibitors; Inositols; Isotope Labelled Compounds; Labeling and Diagnostics Reagents; Lipids; Lysergic Acid and Derivatives; Maleimide Derivatives; Mercaptans/Thiols; Metabolites; Methadones and Analogues; Miscellaneous Compounds; Morphine Based Alkaloids; MTS & Sulfhydryl Active Compounds; Mutagenesis Research Chemicals; Neurochemicals; Neutral Bifunctional Reagents; Neutral Monofunctional Reagents; Nicotine Derivatives; Nitric Oxide Reagents; Non-nucleoside Reverse Transcriptase; Nucleotides; Oligosaccharides; Opium Alkaloids - Natural and Derivatives; Peptides; Pharmaceuticals; Phenethylamines; Phosphorylating and Phosphitylating Agents; Phosphorylcholine Derivatives; Photoaffinity Labels; Polyethyleneglycol Derivatives; Polymers; Protein Kinase Inhibitors and Activators; Pyridyl Disulfides; Retinoids; Selenium Compounds; Sphingosine Derivatives; Spin Labeling Compounds; Steroids; Sulfonyl Chlorides; Tyrosine Kinase Inhibitors; Wittig Reagents.

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Toronto Research Chemicals">
Toronto Research Chemicals
...
阅读详情
Rieke Metals.jpg

Rieke Metal公司位于美国内布拉斯加州Lincoln市,制造有机卤化锌和聚3-烷基噻吩产品。Rieke Metal提供超过5000种有机金属构件模块及超过40000种精细化学品,并且能够提供定制生产服务。

 

From the Rieke Metals headquarters in Lincoln, Nebraska, we manufacture the broadest line of organozinc halides and poly-3-alkylthiophenes of any company in the world. We offer over 5,000 organometallic building blocks and over 40,000 fine chemicals with the ability to custom manufacture many more. The Rieke team has over 135 years of shared experience conducting inert atmosphere reactions. Our expertise in creating reliable organozinc and Grignard reagents, fine chemicals, semiconducting polymers is unmatched. It’s no surprise that Rieke Metals has been honored to serve many of the largest and most innovative pharmaceutical and electronics companies in the world.

 

Rieke Metals公司主要产品:

1000 - Rieke® Highly Reactive Metals

2000 - Rieke® Organozinc Reagents

3000 - Grignard Reagents

4000 - Rieke® Specialty Conducting Polymers

4100 - Substituted Thiophenes

5000 - Functionalized Benzophenones

5500 - Heterocyclic Ketones

6000 - Functionalized Ketones

6250 - Functionalized Benzoylacetonitriles

6500 - Functionalized Trifluoromethyl Ketones

7000 - Functionalized Ketoacids

7500 - Functionalized Ketoesters

8000 - Functionalized Aldehydes and Acetals

8500 - Functionalized Ketoacetals

9000 - 1-Keto-3-Protected Aldehydes

10000 - Functionalized Terminal Alkenes

11000 - Biphenyls (Heterocyclic, Bipyridines, and Pyridyl Phenylamines)

14000 - Alpha-Ketoesters and Acids

18000 - Cyclopentane Dicarboxylic Acids, Anydrides, Ester Acids, and Derivatives

18500 - Cyclohexane Dicarboxylic Acids, Anydrides, Ester Acids, and Derivatives

Novel Chemical Synthesis fine organic compounds

Novel Chemical Synthesis Grignard reagents

Novel Chemical Synthesis organozinc reagents

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Rieke Metals">
Rieke Metals
...
阅读详情
Novus Biologicals.jpg

Novus Biologicals,抗体一站式服务专家。作为世界上最大的抗体生产商,Novus Biologicals 携近16万种抗体席卷而来,完美解决您的需求。

 

The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences. Novus Biologicals is also organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supply materials to serve these trends. By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research.

 

All of Novus Biologicals products are supplied with detailed technical information and ongoing support. By serving both niche and emerging markets, Novus Biologicals has built solid partnerships with our customers. Contact us for more information.

 

Novus的主要产品包括:

(1)Antibodies

Primary Antibodies

Conjugated Antibodies

Sample Size Antibodies

Antibody Sampler Packs

Antibody Pairs

Secondary Antibodies

Isotype Control Antibodies

(2)Proteins and Peptides

Peptides & Proteins

Blocking Peptides

Biologically Active Proteins

(3)Lysates and Cell Lines

Lysates

Reporter Cell Lines

Stem Cell Lines

(4)Kits

Antibody Labeling Kits

ChIP Kits

ELISA Kits

Flow Cytometry Kits

Exosome Kits

(5)Activators and Inhibitors

Inhibitors

Activators

(6)Support Products

IHC Tissue Slides

IHC Microarrays

Western Blot Membranes

RNAi

All Support Products

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Novus Biologicals">
Novus Biologicals
...
阅读详情
R&D Systems.jpg

R&D Systems位于美国的明尼苏达州,一直致力于生物制品的开发与生产。公司成立之初主要生产用于医院及临床应用的血控品。1977年,公司推出第一个产品--富血小板血浆质控品;1981年,公司成为全球第二家生产含血小板全血控品的供应商。40多年的发展中,R&D Systems仍持续开发各种血控品产品。

 

1985年,作为公司推出的第一个科研试剂产品,也是全球第一家将该产品进行商业化生产的产品,R&D Systems成功上市了TGF-beta1蛋白。作为胞外信号分子,TGF-beta1蛋白在多种细胞中进行表达,并作为胞外信号分子参与免疫功能,细胞增殖和细胞分化等生物学过程。该产品推出后,公司陆续从生物材料中纯化了几种细胞因子产品并推向市场。天然蛋白类产品的成功推广,加速了R&D Systems在细胞因子市场的开拓。公司于1985年形成Growth Factor事业部(现Biotechnology事业部)。Biotechnology事业部的目标是生产和营销重组人细胞因子。与天然来源提取蛋白相比较,DNA重组技术生产的蛋白产品其成本更低,产量更高,完全摆脱原料的限制。1989年,Biotechnology事业部开始开发抗细胞因子的单克隆和多克隆抗体,并于1990年开发了第一个ELISA试剂盒。

 

R&D System的主要产品包括:

Recombinant Proteins

GMP Proteins

Antibodies

ELISAs

Luminex Assays & High Performance Assays

Stem Cell Products

Cell Culture

Small Molecules & Peptides

Enzymes

ELISpots

cDNA Clones

Flow Cytometry Workflow Solutions

Proteome Profiler Antibody Arrays

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="R&D System">
R&D System
...
阅读详情
Astrabiotech 2.5比1.png

<

艾美捷科技代理Astra Biotech品牌全系列产品


Astra Biotech GmbH成立于2009年,专注于体外诊断(IVD)领域。Astra Biotech的产品目录包含用于检测激素紊乱、代谢疾病、肿瘤标志物以及过敏测试的试剂和体外诊断产品,其产品均基于可靠的ELISA技术或灵敏的PCR反应,所有ELISA试剂盒和PCR检测均通过CE认证,并经过严格的质量控制。


▍Astra Biotech产品线

● 抗体产品:高亲和力鼠源单克隆抗体(Mabs),靶向人源激素及蛋白靶点。

● 抗原原料:从培养上清液中分离,经凝胶层析、透析或亲和层析纯化的高纯度抗原。

● HRP 偶联物:抗体/抗原与辣根过氧化物酶(HRP)的活性偶联复合物。

● 校准品系统:含超高纯度抗原的血清基质校准品套装。

● 微孔板:预包被抗体或抗原的固相载体微孔板。

 ELISA 试剂盒:用于检测激素相关性疾病、感染性疾病、肿瘤标志物及过敏原的酶联免疫检测试剂盒。

● 分子遗传学产品:面向分子遗传性疾病诊断的PCR检测试剂盒。

 重组蛋白产品:源于大肠杆菌或哺乳动物细胞系的重组蛋白/重组过敏原,适用于ELISA及Western Blot实验。

● 过敏原检测试剂:用于特异性IgE检测的生物素化过敏原。

● PCR 反应体系:即用型实时荧光定量PCR预混液、电泳试剂及多系列聚合酶。


AstraBiotech页面.png


▍Astra Biotech部分产品列表


品名货号
DHEA-Sulfate ELISA kitREF 20-01
Cortisol ELISA kitREF 20-02
Anti-TPO ELISA kitREF 24-06
Anti-TG ELISA kitREF 24-07
TG ELISA kitREF 24-08
CA-125 ELISA kitREF 30-01
Gonadotropin hCG ELISA kitREF 22-01
AFP ELISA kitREF 22-02
Ferritin ELISA kitREF 40-01
Ferritin ELISA kitREF 40-01
Total IgE ELISA kitREF 50-01
Chlamydia trachomatis PCR KitREF 84-11-56
Neisseria gonorrhoeae PCR kitREF 84-03
Neisseria gonorrhoeae PCR kitREF 84-04
Neisseria gonorrhoeae PCR kitREF 84-01
Trichomonas vaginalis PCR kitREF 84-05
Trichomonas vaginalis PCR kitREF 84-06
Trichomonas vaginalis PCR kitREF 84-02
Anti-AFP-mouse-mAb (IgG1)10-01
Anti-AFP-mouse-mAb (IgG1)10-02
Anti-Testosterone-mouse-mAb (IgG1)10-03
Anti-Progesterone-mouse-mAb (IgG2b)10-04
Anti-L-thyroxin-mouse-mAb (IgG2b)10-05
Anti-hCG-mouse-mAb (IgG1)10-06
Anti-hCG-mouse-mAb (IgG1)10-07
Anti-Prolactin-mouse-mAb (IgG2a)10-08
Anti-Prolactin-mouse-mAb (IgG1)10-09
Anti-Cortisol mouse Mab (IgG2a)10-10
Anti-CA-125-mouse-mAb (IgG1)10-11
Anti-CA-125-mouse-mAb (IgG1)10-12
Anti-Triiodothyronine-mouse-mAb (IgG1)10-13
Cortisol-HRP Conjugate12-01
Progesterone-HRP Conjugate12-02
Testosterone-HRP Conjugate12-03
DHEA-HRP Conjugate12-04
T3-HRP Conjugate12-05
T4-HRP Conjugate12-06
Anti-IgE-HRP Conjugate14-01
Anti-AFP-HRP Conjugate14-04



" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Astra Biotech品牌全系列产品">
艾美捷科技代理Astra Biotech品牌全系列产品
...
阅读详情
R&D Systems.jpg

R&D Systems位于美国的明尼苏达州,一直致力于生物制品的开发与生产。公司成立之初主要生产用于医院及临床应用的血控品。1977年,公司推出第一个产品--富血小板血浆质控品;1981年,公司成为全球第二家生产含血小板全血控品的供应商。40多年的发展中,R&D Systems仍持续开发各种血控品产品。

 

1985年,作为公司推出的第一个科研试剂产品,也是全球第一家将该产品进行商业化生产的产品,R&D Systems成功上市了TGF-beta1蛋白。作为胞外信号分子,TGF-beta1蛋白在多种细胞中进行表达,并作为胞外信号分子参与免疫功能,细胞增殖和细胞分化等生物学过程。该产品推出后,公司陆续从生物材料中纯化了几种细胞因子产品并推向市场。天然蛋白类产品的成功推广,加速了R&D Systems在细胞因子市场的开拓。公司于1985年形成Growth Factor事业部(现Biotechnology事业部)。Biotechnology事业部的目标是生产和营销重组人细胞因子。与天然来源提取蛋白相比较,DNA重组技术生产的蛋白产品其成本更低,产量更高,完全摆脱原料的限制。1989年,Biotechnology事业部开始开发抗细胞因子的单克隆和多克隆抗体,并于1990年开发了第一个ELISA试剂盒。

 

R&D System的主要产品包括:

Recombinant Proteins

GMP Proteins

Antibodies

ELISAs

Luminex Assays & High Performance Assays

Stem Cell Products

Cell Culture

Small Molecules & Peptides

Enzymes

ELISpots

cDNA Clones

Flow Cytometry Workflow Solutions

Proteome Profiler Antibody Arrays

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="R&D System">
R&D System
...
阅读详情
Milenia Biotec.jpg

Milenia Biotec为全世界生物医药、诊断企业和研究机构提供高品质的免疫诊断试剂盒。

 

Milenia Biotec offers immunodiagnostic kits, that are distributed worldwide from our headquarters in Giessen. Our test systems help to carefully and rapidly diagnose various diseases. The results are the basis for medical doctors to do a targeted therapeutic approach. Therefore unneccessary therapies or hospital admissions can be saved and patients can be more comfortable.

 

Our tests are very simple to run and they can be done at every location. For the calculation of results only minimal equipment is required. For instance, the "PolyCheck" products are read on a standard flat bed scanner. The lateral flow technology, on which our "QuickLine" Assays are based, even allows testing without any instrumentation!

 

Milenia Biotec公司的产品主要有:

产品名称

产品编号

产品描述

Acanthocheilonema   viteae (OWN) - IgG Antibodies

AF   9400

Item   number: AF 9400
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off  test
  Range: pNPP, λ=405   nm
  Sample volume:10 μl   serum for pre-dilution

HAMA

MQHM   Z

Item   number: MQHM Z
  Package size: 5 Tests
  Test procedure: 10 min RT
  Evaluation: quality based on evaluation card
  Sample volume: 50 μl   serum
  Specificity: IgG antibodies against mouse IgG

HIT

MQHIT Z; MQHIT 1

  Item number; MQHIT Z; MQHIT 1
  Package size: 5 Tests; 20 Tests
  Test procedure: 10 min RT
  Evaluation quality based on evaluation card
  Range: n.a.
  Detection limit: n.a.
  Sample volume: 5 μl serum
  Specificity IgG antibodies against PF4 / polyanion-complexes

HIT   Positive Control

MQCOHIT 1

Item   Number: MQCOHIT 1
  Package size: 1 x 1 Fl. à 0,25 ml
  for analyte: IgG antibodies against PF4 / polyanion complexes
  Concentration: positive
  Evaluation: visually

IL-6

MQL6 1

Item   number: MQL6 1
  Package size: 20 Tests
  Test procedure: 20 min RT
  Range: ≤ 50 bis ≥ 10.000 pg/ml
  Detection limit: 50 pg/ml
  Sample volume: 100 μl serum, plasma, liquor or culture supernatant

IL-6   Control

MQCO6 1

Item   Number: MQCO6 1
  Package size: 2 x 3 Fl.
  for analyte: IL6
  Concentration: Two areas
  Evaluation: only Milenia® POCScan Reader

Aspergillus   fumigatus - IgG Antibodies

AF 6100

Item   number: AF 6100
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Echinococcus   multilocularis Em2 - Em18 Antibodies IgG

AF 9300

Item   number: AF 9300
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Echinococcus   multilocularis Em18 Antibodies IgG

AF 9310

Item   number: AF 9310
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Echinococcus   granulosus (dog tapeworm) - IgG Antibodies

AF   9350

Item   number: AF 9350
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Leishmania   infantum - IgG Antibodies

AF 9500

Item   number: AF 9500
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Entamoeba   histolytica - IgG Antibodies

AF 9550

Item   number: AF 9550
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Microsporidia

 AF 8100

Item   number: AF 8100
  Package size: 2 x 50 Tests
  Test procedure: 10 min (-)20° C + 70 min RT
  Sample volume: 2 μl stool suspension

Schistosoma   mansoni IgG

AF 9600

Item   number: AF 9600
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Enzyme   immunoassay in microplate format with 12 x 8 strips

AF 9450

Item   number: AF 9450
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range: pNPP, λ=405 nm
  Sample volume: 10 μl serum for pre-dilution

Toxocara   canis (roundworm) - IgG Antibodies

AF 9200

Item   number: AF 9200
  Package size: 96 Tests
  Test procedure: 15 min RT + 1,5 h 37° C
  Standard range: quality based on cut-off test
  Range
  Sample volume: 10 μl serum for pre-dilution

Milenia®   GenLine Universal modul

MGUP 1

Item   number: MGUP 1
  Package size: 48 Tests
  Test procedure: 55 min (50 min Thermocycler + 5 min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: n.a.
  Sample volume: 2 µl
  Specificity: Amplifikate der Milenia GenLine PCR Module

Milenia®   GenLine Lactobacillus/Pediococcus Screen

MGScLP 1

Item   number: MGScLP 1
  Package size: 48 Tests
  Test procedure: 55 min (50 min Thermocycler + 5 min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: 10^4 – 10^5 germs/ml
  Sample volume: 2 µl
  Specificity: Bierschädigende Lactobacillen und Pediococcen

Milenia®   GenLine Megasphaera/Pectinatus Screen

MGScMP 1

Item   number: MGScMP 1
  Package size: 48 Tests
  Test procedure: 55 min (50 min Thermocycler + 5 min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: 10^4 – 10^5 gems/ml
  Sample volume: 2 µl
  Specificity: Bierschädigende Megasphaeren und Pectinaten

Milenia®   GenLine Lactobacillus brevis

MGLBR Z

Item   number: MGLBR Z
  Package size: 24 Tests
  Test procedure: 55 min (50 min Thermocycler + 5 min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: 10^4 – 10^5 germs/ml
  Sample volume: 2 µl
  Specificity: Bierschädigender Lactobacillus brevis

Milenia®   GenLine Hop Resistance Screen Kit

MGHOR 1

Item   number: MGHOR 1
  Package size: 48 Tests
  Test procedure: 55 min (50 min Thermocycler + 5 min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: n.a.
  Sample volume: 2 µl
  Specificity: HOR A and HOR C Gene

HybriDetect

MGHD 1

Item   number: MGHD 1
  Package size: 100 Tests
  Sample volume: 100 μl

HybriDetect   2T

MGHD2 1

Item   number: MGHD2 1
  Package size: 100 Tests
  Sample volume: 100 μl

Milenia®   Mouse Immunoglobulins-universal module

MQUM 1

Item   number: MQUM 1
  Package size: 100 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse immunoglobulins

Milenia®   Mouse IgG1

MQSBG1

Item   number: MQSBG1
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgG1

Milenia®   Mouse IgG2a

MQSBG2A

Item   number: MQSBG2A
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgG2a

Milenia®   Mouse IgG2b

MQSBG2B

Item   number: MQSBG2B
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgG2b

Milenia®   Mouse IgG2c

MQSBG2C

Item   number: MQSBG2C
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgG2c

Milenia®   Mouse IgG3

MQSBG3


  Item number: MQSBG3
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgG3

Milenia®   Mouse IgM

MQSBM

Item   number: MQSBM
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgM

Milenia®   Mouse IgA

MQSBA

Item   number: MQSBA
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse IgA

Milenia®   Mouse kappa

MQSBKLC

Item   number: MQSBKLC
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse kappa

Milenia®   Mouse lambda

MQSBLLC

Item   number: MQSBLLC
  Package size: 10 Tests
  Test procedure: 5 min RT
  Evaluation: qualitatively visually
  Standard range: n.a.
  Detection limit: 1 - 20 µg/ml
  Sample volume: 10 µl
  Specificity: Mouse lambda

Milenia®   GenLine Alicyclobacillus Screen

MGScACB   1

Item   number: MGScACB 1
  Package size: 48 Tests
  Test procedure: 75 min (20 min Sample Processing + 55 min Thermocycler + 5   min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: 10^3 – 10^4 germs/ml
  Sample volume: 2 µl
  Specificity: Beverage-damaging Alicyclobacillen

Milenia®   GenLine Alicyclobacillus acidoterrestris / Guajacol

MGAaG   Z

Item   number: MGAaG Z
  Package size: 24 Tests
  Test procedure: 75 min (20 min Sample Processing + 55 min Thermocycler + 5   min RT)
  Evaluation: qualitatively
  Standard range: n.a.
  Detection limit: 10^3 – 10^4 germs/ml
  Sample volume: 2 µl
  Specificity: Alicyclobacillus acidoterrestris and ability to form guaiacol

Milenia®   GenLine Extraction buffer

MGEXBA

Item   number: MGEXBA
  Package size: 10 ml

Milenia®   GenLine Swab Detection Buffer

MGSDB

Item   number: MGSDB
  Package size: 10 ml



更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Milenia Biotec">
Milenia Biotec
...
阅读详情
QED Bioscience.jpg

QED Bioscience致力于为生物医药行业提供各类高品质抗体。

 

QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.

 

QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full-service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.

 

QED Bioscience的主要产品包括:

Agriculture and Food Science Antibodies

Anti-Immunoglobulin Antibodies

Apoptosis Antibodies

Autophagy Antibodies

BioWarfare Antibodies

Cancer Research Antibodies

Cell Adhesion Molecule Antibodies

Coagulation Factor Antibodies

DNA/RNA/Oxidative Stress Antibodies

Drug Antibodies

Enzymes and Enzyme Inhibitor Antibodies

Epitope Tag Antibodies

Growth Factors/Cytokines/Receptor Antibodies

Heat Shock and Stress Protein Antibodies

Hormones and Serum Protein Antibodies

Infectious Disease Antibodies

Ion Channel Antibodies

Matrix Protein/MMP Antibodies

Neuroscience and Signal Transduction Antibodies

Phospho-specific Antibodies

Protein Transcription Antibodies

Reproductive Biology Antibodies

Secondary Antibodies

<

更多详情请联系 

艾美捷科技有限公司

全国服务热线:400-6800-868

邮箱:sales@amyjet.com

网站:www.amyjet.com


" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="QED Bioscience">
QED Bioscience
...
阅读详情
ATTO Biotech.jpg

艾美捷科技代理ATTO Biotech全系列产品。

ATTO Biotech专注于开发和提供生命科学研发用的创新产品及服务。公司位于中国上海,主要为全球生物医药类企业及研发机构提供高度专业化的细胞培养材料和技术服务。爱拓生物科技推出的含组织特异性基质成分细胞培养添加剂,突破了传统细胞培养技术的瓶颈,为全球医药和医学生物学研究者提供了简单、精确和高效的解决方案,是划时代技术革命性产品。

 

ATTO BIOTECH is a German company based inShanghaiChina. We are no giant on an international scale but a global leader in producing cell culture supplements containing tissue-specific decellularized extracellular matrix (ECM) components. Customers choose ATTO BIOTECH for its true research tools of tomorrow to create clinically relevant in vitro solutions that fundamentally change the way we understand human diseases. Our range of highly innovative products has wide applications in life sciences industries and academic institutions.

 

主要产品包括:

心脏组织特异性细胞外基质添加剂

(Cat# ECM201) heart-specific ECM supplements (hECMs), 10×

动/静脉血管组织特异性细胞外基质添加剂

(Cat# ECM202) artery/vein-specific ECM supplements (aECMs/vECMs), 10×

脑组织特异性细胞外基质添加剂

(Cat# ECM203) brain-specific ECM supplements (bECMs), 10×

胃肠组织特异性细胞外基质添加剂

(Cat# ECM204) gastrointestine-specific ECM supplements (gECMs), 10×

食管组织特异性细胞外基质添加剂

(Cat# ECM205) esophagus-specific ECM supplements (eECMs), 10×

肾胀组织特异性细胞外基质添加剂

(Cat# ECM206) kidney-specific ECM supplements (kECMs), 10×

肝组织特异性细胞外基质添加剂

(Cat# ECM207) liver-specific ECM supplements (liECMs), 10×

脾组织特异性细胞外基质添加剂

(Cat# ECM208) spleen-specific ECM supplements (sECMs), 10×

肺组织特异性细胞外基质添加剂

(Cat# ECM209) lung-specific ECM supplements (luECMs), 10×

气管组织特异性细胞外基质添加剂

(Cat# ECM210) trachea-specific ECM supplements (tECMs), 10×

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ATTO Biotech">
ATTO Biotech
...
阅读详情
Berry & Associates.png

艾美捷科技代理Berry & Associates全系列修饰核苷酸等


美国 Berry & Associates 公司成立于1989年,提供近200种亚磷酰胺和核苷酸合成用固相交联单体,以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

 

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry.  High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.


Berry & Associates的主要产品包括:

产品名称产品编号纯度规格
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2'-3'-DideoxyguanosinePR 3505≥95%25 mg; 100 mg
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
2',3'-DideoxyuridinePY 7278≥97%100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridinePY 7279≥97%25 mg; 100 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
2-Amino-2'-deoxyadenosinePR 3060≥97%1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosinePR 3080≥95%100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosinePR 3130≥95%100 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purinePR 3670≥95%100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purinePR 3070≥97%25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purinePR 3160≥97%100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine HemihydratePR 3180≥97%25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purinePR 3680≥97%100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosinePR 3006≥95%25 mg; 100 mg
8-Amino-2'-deoxyadenosinePR 3115≥97%10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosinePR 3120≥90%100 mg; 1 g
8-Azido-2'-deoxyadenosinePR 3125≥97%10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosinePR 3230≥95%50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosinePR 3260≥95%100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosinePR 3280≥97%100 mg; 1 g
8-Bromo-2'-deoxyadenosinePR 3290≥90%2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3320≥95%100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosinePR 3340≥97%0g (discontinued);  
2'-Deoxyadenosine MonohydratePR 3445≥97%25 g; 100 g
2',3'-DideoxyadenosinePR 3495≥95%25 mg; 100 mg
2-Fluoro-2'-deoxyadenosinePR 3496≥97%25 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
N6-Methyl-2'-deoxyadenosinePR 3740≥97%100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridinePRA 10012≥95%10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosinePRA 10032≥95%10 mg; 50 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosinePR 3010≥90%0Discontinued;  
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3015≥90%1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3020≥90%1 g; 10 g
5'-Azido-5'-deoxyguanosinePR 3225≥90%5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosinePR 3285≥90%1 g; 10 g
8-Bromo-2'-deoxyguanosinePR 3300≥90%1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosinePR 3310≥97%500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosinePR 3330≥90%250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosinePR 3335≥95%100 mg; 1 g
2'-Deoxyguanosine monohydratePR 3452≥97%10 g; 100 g
α-2'-DeoxyguanosinePR 3455≥97%10 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosinePR 3600≥97%100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosinePR 3605≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosinePR 3630≥97%100 mg; 1 g
N2-Ethyl-2'-deoxyguanosinePR 3700≥95%25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosinePR 3745≥97%10 mg; 100 mg
N1-Methyl-2'-deoxyguanosinePR 3748≥97%25 mg; 1 g
N2-Methyl-2'-deoxyguanosinePR 3750≥97%25 mg; 100 mg
O6-Methyl-2'-deoxyguanosinePR 3755≥90%5 mg; 25 mg
6-Thio-2'-deoxyguanosinePR 3845≥97%10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3090≥97%250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosinePR 3110≥95%250 mg; 1 g
2-Amino-N2-O-methyladenosinePR 3150≥97%1 g; 10 g
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
2'-O-MethyladenosinePR 3734≥97%1 g;  
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridinePY 7575≥97%10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridinePY 7577≥97%10 mg; 100 mg
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosinePR 3000≥97%25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosinePR 3200≥90%50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosinePR 3210≥97%10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosinePR 3220≥97%10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosinePR 3240≥97%100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosinePR 3250≥97%100 mg; 1 g
3'-DeoxyadenosinePR 3430≥97%10 mg; 100 mg
3'-DeoxyguanosinePR 3460≥97%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosinePR 3590≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosinePR 3690≥97%20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridinePY 7230≥97%100 mg;  
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3040≥97%1 g;  
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3045≥95%1 g;  
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purinePR 3050≥95%5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purinePR 3370≥97%100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purinePR 3380≥90%100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purinePR 3390≥97%0 g;  
6-Chloro-9-(β-D-ribofuranosyl)purinePR 3400≥97%5 g; 10 g
AdenosinePR 3005≥97%100 g; 1 kg
8-MethyladenosinePR 3007≥95%25 mg; 100 mg
VidarabinePR 3008≥97%1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)PR 3030≥97%2 g; 10 g
N1-Methyladenosine hydroiodidePR 3032≥95%100 mg; 1 g
2-MethyladenosinePR 3035≥97%10 mg; 25 mg
5'-Chloro-5'-deoxyadenosinePR 3360≥97%100 mg; 1 g
N6-MethyladenosinePR 3732≥97%100 mg; 1 g
N6-Methyl-2'-O-MethyladenosinePR 3733≥97%50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosinePRA 10013≥97%10 mg; 25 mg
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10000≥97%100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidinePRA 10005≥97%500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridinePRA 10006≥90%25 mg; 100 mg
8-AzaadenosinePRA 10007≥97%20 mg;  
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)PRA 10008≥95%10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidinePRA 10009≥95%100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosinePRA 10010≥97%100 mg; 1 g
Allopurinol ribosidePRA 10011≥97%25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosinePRA 10019≥97%500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosinePRA 10020≥97%100 mg; 1 g
3-Deaza-2'-deoxyadenosinePRA 10025≥97%25 mg; 100 mg
7-Deaza-2'-deoxyadenosinePRA 10030≥97%100 mg; 1 g
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 100 mg
5-Iodo-2'-deoxytubercidinPRA 10036≥95%10 mg; 50 mg
7-Deaza-2'-deoxyguanosinePRA 10040≥97%100 mg; 1 g
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
7-Deaza-2'-deoxyxanthosinePRA 10050≥97%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosinePRA 10055≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
5-IodotubercidinPRA 10095≥90%5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10100≥97%100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosinePRA 10110≥97%100 mg; 1 g
SangivamycinPRA 10140≥97%10 mg; 25 mg
ToyocamycinPRA 10150≥97%10 mg; 100 mg
TriciribinePRA 10160≥97%10 mg;  
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg;  
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
dNaMFC 8110≥97%25 mg; 100 mg
9-Deaza-2'-deoxyguanosinePRA 10120≥97%10 mg; 100 mg
9-DeazaguanosinePRA 10130≥97%10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazinePYA 11000≥97%10 mg; 25 mg
Formycin APYA 11001≥97%10 mg;  
Formycin BPYA 11002≥97%10 mg;  
PyrazofurinPYA 11004≥97%10 mg;  
2'-DeoxypseudoisocytidinePYA 11005≥97%10 mg; 100 mg
2'-DeoxypseudouridinePYA 11010Purity: ≥97%25 mg; 
5'-O-(Dimethoxytrityl)-N-(dimethylamino)
methylidene-2'-deoxypseudoisocytidine
PYA 11035Purity: ≥97%50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridinePYA 11040≥97%10 mg; 100 mg
1,3-DimethylpseudouridinePYA 11050≥97%10 mg; 50 mg
N1-MethylpseudouridinePYA 11052≥95%10 mg; 50 mg
N3-MethylpseudouridinePYA 11054≥97%10 mg; 25 mg
ShowdomycinPYA 11056≥97%10 mg;  
Pseudoisocytidine hydrochloridePYA 11060≥97%10 mg; 100 mg
PseudothymidinePYA 11070≥97%10 mg; 100 mg
PseudouridinePYA 11080≥97%10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosinePR 3350≥97%10 mg;  
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-Deoxy-8,5'-cycloadenosinePR 3440≥97%10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosinePR 3500≥97%10 mg;  
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosinePR 3730≥97%10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosinePR 3800≥97%10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosinePR 3810≥97%10 mg;  
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7010≥95%0 g DISCONTINUED;  
N4-Acetyl-5'-methyl-2'-O-methylcytidinePY 7020≥97%0 g DISCONTINUED;  
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidinePY 7054≥97%25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidinePY 7080≥97%20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidinePY 7100≥95%100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidinePY 7110≥97%500 mg; 1 g
5-Bromo-2'-deoxycytidinePY 7115≥97%1 g; 10 g
CytidinePY 7215≥97%50 g; 500 g
2'-DeoxycytidinePY 7216≥97%10 g; 50 g
2'-Deoxycytidine HydrochloridePY 7217≥97%5 g; 50 g
5'-Azido-2',5'-dideoxycytidinePY 7219≥97%25 mg; 100 mg
3'-DeoxycytidinePY 7220≥97%20 mg; 100 mg
N4-Ethyl-2'-deoxycytidinePY 7245≥97%100 mg; 250 mg
5-Methyl-2'-deoxyisocytidinePY 7255≥95%500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7270≥97%20 mg; 50 mg
2',3'-DideoxycytidinePY 7325≥95%50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidinePY 7350≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidinePY 7360≥97%0     DISCONTINUED;  
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidinePY 7370≥97%0     DISCONTINUED;  
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-onePY 7380≥97%50 mg;  
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidinePY 7400≥97%100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidinePY 7410≥97%100 mg;  
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-onePY 7540≥95%250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydratePY 7586≥95%50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidinePY 7587≥97%10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidinePY 7588≥97%50 mg; 100 mg
5-Formyl-2'-deoxycytidinePY 7589≥97%5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidinePY 7592≥95%25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium saltPY 7593≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-HydroxymethylcytidinePY 7596≥97%50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium saltPY 7598≥97%10 mg; 50 mg
5-FormylcytidinePY 7599≥97%5 mg; 10 mg
5-Iodo-2'-deoxycytidinePY 7607≥97%2 g; 10 g
5-IodocytidinePY 7609≥97%5 g;  
5-Iodo-2'-O-methylcytidinePY 7620≥90%20 mg; 100 mg
5-Methyl-2'-deoxycytidine HydrochloridePY 7635≥97%0.25 g; 1 g
2'-O-MethylcytidinePY 7636≥97%1 g; 5 g
5-MethylcytidinePY 7637≥97%1 g; 5 g
N4-MethylcytidinePY 7638≥97%25 mg; 100 mg
5-Methyl-2'-O-methylcytidinePY 7640≥97%100 mg; 500 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidinePY 7660≥95%10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidinePY 7700≥90%5 mg; 10 mg
2-ThiocytidinePY 7721≥97%10 mg; 100 mg
2-Thio-2'-deoxycytidinePY 7723≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosinePR 3270≥97%100 mg; 1 g
(5'S)-8,5'-CycloadenosinePR 3410≥97%10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosinePR 3420≥97%10 mg;  
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3610≥97%100 mg; 1 g
8-Oxo-2'-deoxyadenosinePR 3705≥95%25 mg; 250 mg
8-Oxo-2'-deoxyguanosinePR 3710≥97%25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosinePR 3720≥90%100 mg; 1 g
8-HydroxyguanosinePR 3795≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
5-Aza-2'-deoxycytidinePY 7105≥95%25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidinePY 7106≥97%25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridinePY 7330≥97%100 mg;  
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
5-Hydroxy-2'-deoxycytidinePY 7595≥95%25 mg; 250 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
6-MethylcytidinePY 7641≥97%10 mg; 25 mg
Nap-dUPY 7735≥97%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidinePYA 11130≥97%100 mg; 500 mg
Pyrrolo-dCPYA 11090≥95%10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-onePYA 11092≥97%10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-onePYA 11095≥95%100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dionePYA 11100≥95%10 mg; 100 mg
8-18O-HydroxyguanosineIOPR 3795≥95%2 mg; 5 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosinePR 3701≥95%25 mg; 100 mg
N2-DimethylguanosinePR 3702≥97%10 mg; 100 mg
GuanosinePR 3703≥97%100 g; 500 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
O6-MethylguanosinePR 3757≥97%25 mg; 100 mg
2'-O-MethylguanosinePR 3760≥97%1 g; 10 g
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
8-BromoguanosinePR 3796≥97%0 g;  
8-BenzyloxyguanosinePR 3797≥95%100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosinePRA 10042≥97%10 mg; 50 mg
7-DeazaguanosinePRA 10045≥97%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
2'-DeoxypseudoguanosinePRA 10103≥97%10 mg; 50 mg
2'-DeoxypseudoisoguanosinePRA 10104≥97%10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindolePRA 10060≥97%100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindolePRA 10070≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindolePRA 10080≥97%0 g;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindolePRA 10090≥97%100 mg; 1 g
2'-Deoxy-4-desmethylwyosinePR 3450≥95%100 mg; 500 mg
2'-DeoxyinosinePR 3463≥97%10 g; 100 g
5'-Azido-2',5'-dideoxyinosinePR 3464≥97%5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosinePR 3480≥97%1 g;  
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosinePR 3490≥90%1 g;  
5'-O-(Dimethoxytrityl)-2'-O-methylinosinePR 3640≥97%1 g;  
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosinePR 3660≥97%100 mg; 1 g
InosinePR 3725≥97%100 g; 500 g
2',3'-DideoxyinosinePR 3727≥97%100 mg; 1 g
2'-O-MethylinosinePR 3770≥97%500 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
O6-Phenyl-2'-deoxyinosinePR 3840≥97%100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3842≥97%25 mg;  
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosinePR 3843≥90%25 mg; 100 mg
2'-DeoxyisoguanosinePR 3465≥97%10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosinePR 3510≥90%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3520≥95%100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosinePR 3530≥90%100 mg; 1 g
IsoguanosinePR 3735≥97%10 mg; 50 mg
d5SICSFC 8120≥97%25 mg; 100 mg
AICA Riboside (AICAR)MN 20001≥97%0 g (DISCONTINUED);  
2',3'-Di-O-methyladenosinePR 3540≥97%100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosinePR 3692≥95%10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosinePRA 10170≥95%10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-onePRA 10175≥95%10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidinePY 7790≥95%10 mg; 25 mg
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
tC NucleosidePYA 11110≥97%50 mg; 100 mg
tCnitro NucleosidePYA 11115≥95%5 mg; 25 mg
2'-DeoxynebularinePR 3470

Purity: ≥97%
100 mg; 1 g
7-MethylinosinePR 3780≥95%100 mg; 250 mg
7-Methyl-6-thioguanosinePR 3790≥75%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrolePYA 11020≥97%50 mg;  
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrolePYA 11030≥95%100 mg;  
ShowdomycinPYA 11056≥97%10 mg; 
Formycin APYA 11001≥97%10 mg; 
Formycin BPYA 11002≥97%10 mg; 
PseudouridinePYA 11080≥97%10 mg; 
PyrazofurinPYA 11004≥97%10 mg; 
ToyocamycinPRA 10150≥97%10 mg; 
7-Deazaadenosine (tubercidin)PRA 10035≥97%10 mg; 
Allopurinol ribosidePRA 10011≥97%25 mg; 
5-IodotubercidinPRA 10095≥90%5 mg; 
TriciribinePRA 10160≥97%10 mg; 
Tricyclic Nucleoside PhosphatePRA 10162≥95%10 mg; 
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dionePRA 10047≥97%10 mg; 
5'-Amino-5'-deoxythymidinePY 7030≥97%25 mg; 50 mg
O2,5'-AnhydrothymidinePY 7060≥95%500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)PY 7065≥97%500 mg; 1 g
5'-Azido-5'-deoxythymidinePY 7070≥97%25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7120≥97%1 g;  
3'-O-(t-Butyldimethylsilyl)thymidinePY 7130≥95%500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidinePY 7140≥97%5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidinePY 7150≥97%1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidinePY 7160≥95%100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidinePY 7200≥95%10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidinePY 7210≥95%10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidinePY 7250≥97%1 g;  
3'-DeoxythymidinePY 7277≥95%50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-onePY 7315≥90%1 g; 10 g
2',3'-Didehydro-3'-deoxythymidinePY 7328≥95%10 mg; 100 mg
(5S)-5,6-DihydrothymidinePY 7340≥97%20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidinePY 7390≥97%100 mg;  
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidinePY 7510≥97%50 mg; 100 mg
2-O-EthylthymidinePY 7561≥97%500 mg; 1 g
5'-Iodo-5'-deoxythymidinePY 7610≥97%250 mg; 1 g
5'-O-MethylthymidinePY 7680≥95%50 mg; 100 mg
2-ThiothymidinePY 7725≥95%20 mg; 100 mg
ThymidinePY 7727≥97%25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidinePY 7740≥97%5 g;  
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidinePY 7750≥97%50 mg;  
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
6-AzathymidinePYA 11058≥95%25 mg; 100 mg
NPOM-Caged-dT CEPBA 0317≥95%100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidinePY 7075≥97%0 g DISCONTINUED;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidinePY 7345≥95%10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
3-(2-Cyanoethyl)thymidinePY 7742≥95%10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
NPOM-Caged deoxythymidinePY 7795≥97%25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-onePYA 11055≥97%5 mg; 25 mg
5-Ethynyl uridine CEPBA 0353≥90%100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridinePY 7000≥97%500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7040≥97%100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridinePY 7050≥90%100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridinePY 7053≥97%25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-onePY 7055≥97%20 mg; 100 mg
5-Bromo-2'-deoxyuridinePY 7117≥97%10 g; 25 g
5-BromouridinePY 7118≥95%5 g;  
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridinePY 7170≥97%1 g;  
(E)-5-(2-Carbomethoxyvinyl)uridinePY 7172≥97%25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridinePY 7180≥97%500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridinePY 7185≥97%1 g;  
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide EsterPY 7190≥97%100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridinePY 7212≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridinePY 7240≥95%25 mg; 100 mg
5-Methyl-3'-deoxyuridinePY 7260≥95%20 mg; 50 mg
2'-DeoxyuridinePY 7275≥97%25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridinePY 7280≥95%100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridinePY 7286≥97%10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7290≥95%500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridinePY 7300≥97%50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7310≥97%20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridinePY 7320≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridinePY 7420≥95%100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridinePY 7450≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridinePY 7460≥97%50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridinePY 7465≥95%10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridinePY 7470≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridinePY 7480≥97%500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridinePY 7490≥95%50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridinePY 7500≥95%25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridinePY 7520≥97%100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7530≥97%100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-onePY 7550≥95%100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridinePY 7560≥95%500 mg; 1 g
5-Ethynyl-2'-deoxyuridinePY 7562≥97%25 mg; 100 mg
5-Ethynyl uridinePY 7563≥97%10 mg; 100 mg
5-Fluoro-2'-deoxyuridinePY 7565≥97%100 mg; 1 g
5-Fluoro-2'-O-methyluridinePY 7570≥97%50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridinePY 7580≥97%25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridinePY 7590≥95%25 mg; 100 mg
5-Hydroxy-2'-deoxyuridinePY 7597≥95%25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridinePY 7600≥95%25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridinePY 7604≥97%25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridinePY 7605≥95%25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridinePY 7612≥95%100 mg;  
5-Iodo-2'-deoxyuridinePY 7615≥97%10 g; 25 g
5-Iodo-2'-O-methyluridinePY 7630≥97%100 mg; 1 g
5-IodouridinePY 7632≥95%5 g; 25 g
5-Methyl-2'-O-methyluridinePY 7650≥97%100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridinePY 7670≥97%10 mg; 25 mg
2'-O-MethyluridinePY 7690≥97%5 g;  
3-MethyluridinePY 7694≥97%25 mg; 100 mg
5-MethyluridinePY 7695≥97%200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridinePY 7710≥97%100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridinePY 7712≥95%10 mg; 100 mg
ZebularinePY 7715≥97%10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridinePY 7720≥90%500 mg; 1 g
2-ThiouridinePY 7724≥97%25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridinePY 7730≥97%1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridinePY 7754≥95%100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridinePY 7758≥97%100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7760≥90%100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridinePY 7770≥95%100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridinePY 7775≥97%100 mg; 1 g
UridinePY 7780≥97%100 g; 500 g
2'3'-O-Isopropylidene uridinePY 7781≥97%5 g; 25 g
5-Hydroxymethyl uridinePY 7782≥97%50 mg; 100 mg
5-MethoxyuridinePY 7783≥97%10 mg; 50 mg
6-Aza-2'-deoxyuridinePYA 11057≥95%50 mg; 100 mg

" data-original="http://pharna.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸">
艾美捷科技代理Berry & Associates全系列修饰核苷酸
...
阅读详情

Copyright © 2026 Powered by phaRNA中国区代理商/公司/官网   sitemap